Company Search:
Advanced Search
Sponsored Links
Retrophin Inc Company Snapshot
Retrophin Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Retrophin Inc with three other companies in this sector in the United States: Galapagos NV (2016 sales of $167.34 million of which 80% was R&D), Foundation Medicine Inc ($116.87 million of which 100% was Diagnostic), and National Research Corporation ($109.38 million of which 100% was Performance Tracking).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Retrophin Inc
  Stock Performance Chart for Retrophin Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 21.51
(Figures in U.S. Dollars)
1 Week -1.3%   13 Weeks -1.1%  
4 Weeks -10.2%   52 Weeks 3.0%  
Retrophin Inc Key Data:
  Ticker: RTRX Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 133,591,000
(Year Ending Jan 2017).
Employees: 135
  Currency: U.S. Dollars Market Cap: 844,927,900
  Fiscal Yr Ends: December Shares Outstanding: 39,280,702
  Share Type: Common Closely Held Shares: 10,320,698
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.